Global Large And Small-Scale Bioprocessing Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

 Large and small-scale bioprocessing are essential components of the biotechnology and pharmaceutical industries that involve using living cells or their components to obtain desired products, such as pharmaceuticals, chemicals, and biofuels. Large-scale bioprocessing refers to the industrial-level production of biological products involving large bioreactors and extensive infrastructure. In contrast, Small-scale bioprocessing consists of the production of biological products on a smaller scale, often for research, development, pilot studies, or niche markets.


Sizing and Forecast
The large and small-scale bioprocessing market size has grown rapidly in recent years. It will grow from $52.59 billion in 2023 to $59.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%.  The growth in the historic period can be attributed to medical industry growth, regulatory standards, technological advancements, pharmaceutical and biotechnology growth, and food safety concerns.

The large and small-scale bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $99.03 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%.  The growth in the forecast period can be attributed to increasing healthcare expenditure, the expansion of pharmaceutical and biotechnology sectors, technological innovations, regulatory pressures, rising awareness of food safety, and the aftermath of the COVID-19 pandemic. Major trends in the forecast period include the adoption of advanced technologies, geographical expansion, outsourcing of sterilization services, sustainable practices, hybrid sterilization techniques, and customized sterilization solutions.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/large-and-small-scale-bioprocessing-global-market-report

Segmentation & Regional Insights
The large and small-scale bioprocessing market covered in this report is segmented –
1) By Product: Bioreactors Or Fermenters, Cell Culture Products, Filtration Assemblies, Bioreactors Accessories, Bags And Containers, Other Products
2) By Mode: In-house, Outsourced
3) By Workflow: Downstream Processing, Fermentation, Upstream Processing
4) By Scale: Industrial Scale, Small Scale
5) By Application: Biopharmaceuticals, Specialty Industrial Chemicals, Environmental Aids

North America was the largest region in the large and small-scale bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large and small-scale bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15845&type=smp


Major Driver Impacting Market Growth
The growing demand for biologics is expected to propel the growth of the large and small-scale bioprocessing market going forward. Biologics refer to medicinal products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The growing demand for biologics is due to advancements in biotechnology, increased understanding of disease mechanisms, and the demand for targeted and personalized therapies. Both large-scale and small-scale bioprocessing are integral to biologics' successful development and commercialization. Small-scale bioprocessing is essential for early-stage development, optimization, and feasibility studies. In contrast, large-scale bioprocessing ensures that biologics are produced efficiently, consistently, and in compliance with regulatory standards for commercial distribution. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics drives the growth of the large and small-scale bioprocessing market.

Key Industry Players
Major companies operating in the large and small-scale bioprocessing market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, 3M Company, Takeda Pharmaceutical Company Ltd., Danaher Corporation, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Becton Dickinson and Company (BD), Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Lonza Group, Sun Pharmaceutical Industries Ltd., GE Healthcare Life Sciences, Sartorius AG, Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd

The large and small-scale bioprocessing market report table of contents includes:
1. Executive Summary

2. Large And Small-Scale Bioprocessing Market Characteristics

3. Large And Small-Scale Bioprocessing Market Trends And Strategies

4. Large And Small-Scale Bioprocessing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Large And Small-Scale Bioprocessing Market Size and Growth


.
.
.
32. Global Large And Small-Scale Bioprocessing Market Competitive Benchmarking

33. Global Large And Small-Scale Bioprocessing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Large And Small-Scale Bioprocessing Market

35. Large And Small-Scale Bioprocessing Market Future Outlook and Potential Analysis

35.1 Large And Small-Scale Bioprocessing Market In 2028 - Countries Offering Most New Opportunities

35.2 Large And Small-Scale Bioprocessing Market In 2028 - Segments Offering Most New Opportunities

35.3 Large And Small-Scale Bioprocessing Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.inf
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model 

Comments

Post a Comment

Popular posts from this blog

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Generative Artificial Intelligence (AI) In Telecom Market Industry Outlook Presents Revenue And CAGR Projections To 2030

Image
  The generative artificial intelligence (AI) in telecom market size has grown exponentially in recent years. It will grow from $0.73 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 53.4%. The growth in the historic period can be attributed to growing mobile subscriber base, increasing telecom data traffic, early adoption of AI in network management, rising demand for personalized customer experiences, expansion of cloud-based telecom solutions. The generative artificial intelligence (AI) in telecom market size is expected to see exponential growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 53.0%. The growth in the forecast period can be attributed to advancements in generative AI models, integration of AI with 5G and future networks, growth in edge computing for real-time analytics, adoption of AI for security and fraud prevention, expansion of AI-driven customer support solutions. M...
Read more